The Winning Way With BTK Inhibitors in CLL

Chair, John C. Byrd, MD, Jacqueline C. Barrientos, MD, MS, and Nicole Lamanna, MD, discuss chronic lymphocytic leukemia in this CME/MOC activity titled “The Winning Way With BTK Inhibitors in CLL: Evidence-Informed Choices on Treatment Selection, Safety, and Therapeutic Sequencing.” For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/VXQ865. CME/MOC credit will be available until January 8, 2024.